Lumida
/ARCL
⌘K
ARCL

ARCL

ARCL
$10.03USD+0.15%+0.02 today

MARKET CAP

179.8M

P/E (TTM)

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$8
$11

The case for & against

Bull & Bear analysis

Bearish

ARC Group Acquisition I Corp (NASDAQ: ARCL) is a Special Purpose Acquisition Company (SPAC) actively seeking to identify and merge with viable businesses, specifically within the dynamic landscape of high-growth sectors. In contrast, ARCL Organics Ltd (BSE: ARCL.BO) operates in India’s manufacturing sector, focusing on the production and sale of chemical-based products, including phenolics, amino resins, and formaldehyde, targeting diverse industries such as automotive and construction chemicals. ARCL Organics positions itself within a growing theme of sustainable manufacturing amidst rising demand for chemical solutions.

Bull says

  • ARCL Organics revenue up 21.05% over 3 years, ROCE 23.53%
  • Cash conversion cycle of 4.6 days highlights operational efficiency
  • Product lineup spans phenolics and amino resins across auto, construction
  • Analysts see 35.05% price gain over next 3 months
  • High earnings yield and strong profitability factor underscore value
  • Robust free cash flow to EV ratio supports growth investments

Bear says

  • ARC SPAC market cap $178.8M with 17.9M shares implies micro-cap liquidity risk
  • Nasdaq deficiency notice could trigger delisting if compliance plan fails
  • 126.5% jump in short interest reflects doubt on merger prospects
  • Adverse leverage profile and weak growth factors heighten financial strain
  • Lack of SPAC track record undermines confidence in finding viable target
  • Sell consensus and high volatility cap upside potential